Downregulation of programmed cell death 4 by inflammatory conditions contributes to the generation of the tumor promoting microenvironment
- 5 August 2010
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 49 (9) , 837-848
Abstract
Ample evidence has shown key roles of inflammation in tumor promotion and carcinogenesis, and tumor‐associated macrophages are known to promote tumor growth and dissemination. Programmed cell death 4 (Pdcd4) is a novel tumor suppressor, and although various studies have revealed that the functions and expression mechanisms of Pdcd4 in tumor promotion, those in regard to inflammation remain unclear. In the present study, we examined whether inflammatory stimuli regulate Pdcd4 expression. 12‐O‐tetradecanoylphorbol 13‐acetate (TPA) suppressed expression of pdcd4 mRNA in human monocytic cell lines (U937, THP‐1). Similarly, the bacterial endotoxin lipopolysaccharide (LPS) downregulated pdcd4 level in mouse RAW264.7 and peritoneal macrophages. Furthermore, conditioned medium from LPS‐stimulated RAW264.7 macrophages suppressed pdcd4 mRNA in RAW264.7 macrophages, and findings obtained with recombinant tumor necrosis factor‐α (TNF‐α) and TNF‐α‐specific siRNA suggested that TNF‐α partly mediates LPS‐triggered Pdcd4 downregulation via an autocrine mechanism. Specific inhibitors of phosphoinositide‐3‐kinase (PI3K) and c‐jun N‐terminus kinase (JNK) restored LPS‐abolished pdcd4 mRNA. Consistently, in MCF7 mammary carcinoma cells, conditioned medium from TPA‐differentiated/activated U937 cells suppressed pdcd4 mRNA. Additionally, knockdown of pdcd4 in RAW264.7 macrophages using siRNA significantly enhanced LPS‐induced TNF‐α protein production, and interferon‐γ, CC chemokine ligand (Ccl) 1, Ccl20, and interleukin‐10 mRNA expression. These results suggest that Pdcd4 suppresses the induction of these inflammatory mediators. Taken together, loss of Pdcd4 in macrophages may be a critical step in establishing the inflammatory environment while that in tumor cells contributes to tumor progression.Keywords
This publication has 39 references indexed in Scilit:
- The role of COX-2 in intestinal inflammation and colorectal cancerOncogene, 2009
- Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune DiseasesImmunity, 2009
- Chemokines as Novel Therapeutic Targets for Inflammatory Bowel DiseaseAnnals of the New York Academy of Sciences, 2009
- The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulationBiology of the Cell, 2009
- Complementary analysis of microRNA and mRNA expression during phorbol 12-myristate 13-acetate (TPA)-induced differentiation of HL-60 cellsBiotechnology Letters, 2008
- Programmed Cell Death 4 inhibits breast cancer cell invasion by increasing Tissue Inhibitor of Metalloproteinases-2 expressionBreast Cancer Research and Treatment, 2008
- Ketamine inhibits tumor necrosis factor-α and interleukin-6 gene expressions in lipopolysaccharide-stimulated macrophages through suppression of toll-like receptor 4-mediated c-Jun N-terminal kinase phosphorylation and activator protein-1 activationToxicology and Applied Pharmacology, 2008
- Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharide-induced inflammation but not in the anti-inflammatory action of glucocorticoidsBMC Genomics, 2007
- S6K1- and ßTRCP-Mediated Degradation of PDCD4 Promotes Protein Translation and Cell GrowthScience, 2006
- Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitorOncogene, 2001